UNICREDIT BANK/PUT/ELI LILLY & CO/800/0.1/17.07.24 Share Price

Warrant

DE000HD5KXC3

Market Closed - BOERSE MUENCHEN 01:11:41 28/06/2024 am IST
0.099 EUR -17.50% Intraday chart for UNICREDIT BANK/PUT/ELI LILLY & CO/800/0.1/17.07.24
Current month-95.35%
1 month-95.73%
Date Price Change
27/24/27 0.099 -17.50%
26/24/26 0.12 0.00%
25/24/25 0.12 -40.00%
24/24/24 0.2 -28.57%
21/24/21 0.28 -24.32%

Real-time BOERSE MUENCHEN

Last update June 28, 2024 at 01:11 am IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer UniCredit UniCredit
WKN HD5KXC
ISINDE000HD5KXC3
Date issued 14/05/2024
Strike 800 $
Maturity 17/07/2024 (20 Days)
Parity 10 : 1
Emission price 5.27
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 5.3
Lowest since issue 0.001
Delta-0.05x
Omega 29.64
Premium12.15x
Gearing626.82x
Moneyness 0.8800
Difference Strike -109 $
Difference Strike %-13.63%
Spread 0.089
Spread %49.44%
Theoretical value 0.1355
Implied Volatility 34.15 %
Total Loss Probability 94.48 %
Intrinsic value 0.000000
Present value 0.1355
Break even 798.55 €
Theta-0.09x
Vega0.02x
Rho-0x

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
909 USD
Average target price
860.5 USD
Spread / Average Target
-5.33%
Consensus